PortfoliosLab logoPortfoliosLab logo
OM vs. MO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OM vs. MO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Outset Medical, Inc. (OM) and Altria Group, Inc. (MO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both stocks are quite close, with OM having a 23.99% return and MO slightly lower at 23.96%.


OM

1D
-9.27%
1M
6.24%
YTD
23.99%
6M
6.73%
1Y
-76.30%
3Y*
-76.05%
5Y*
-63.30%
10Y*

MO

1D
1.53%
1M
-4.24%
YTD
23.96%
6M
24.61%
1Y
24.64%
3Y*
25.16%
5Y*
15.82%
10Y*
7.78%
*Multi-year figures are annualized to reflect compound growth (CAGR)

OM vs. MO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
OM
Outset Medical, Inc.
23.99%-77.72%-79.48%-79.05%-43.98%-18.91%-6.33%
MO
Altria Group, Inc.
23.96%18.17%40.76%-3.70%4.37%24.18%-2.20%

Correlation

The correlation between OM and MO is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.04

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Sep 16, 2020

0.06

The correlation between OM and MO shifts across timeframes, from -0.07 (1 year) to 0.07 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

OM:

$84.52M

MO:

$117.61B

EPS

OM:

-$4.17

MO:

$4.79

PS Ratio

OM:

0.70

MO:

5.41

Total Revenue (TTM)

OM:

$117.59M

MO:

$21.82B

Gross Profit (TTM)

OM:

$47.78M

MO:

$14.80B

EBITDA (TTM)

OM:

-$62.73M

MO:

$11.70B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Outset Medical, Inc.

Altria Group, Inc.

Return for Risk

OM vs. MO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OM
OM Risk / Return Rank: 99
Overall Rank
OM Sharpe Ratio Rank: 99
Sharpe Ratio Rank
OM Sortino Ratio Rank: 88
Sortino Ratio Rank
OM Omega Ratio Rank: 77
Omega Ratio Rank
OM Calmar Ratio Rank: 66
Calmar Ratio Rank
OM Martin Ratio Rank: 1414
Martin Ratio Rank

MO
MO Risk / Return Rank: 6969
Overall Rank
MO Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
MO Sortino Ratio Rank: 6666
Sortino Ratio Rank
MO Omega Ratio Rank: 6868
Omega Ratio Rank
MO Calmar Ratio Rank: 6868
Calmar Ratio Rank
MO Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OM vs. MO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Outset Medical, Inc. (OM) and Altria Group, Inc. (MO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OMMODifference
Sharpe ratioReturn per unit of total volatility

-1.90

Sortino ratioReturn per unit of downside risk

-2.79

Omega ratioGain probability vs. loss probability

0.83

1.22

-0.39

Calmar ratioReturn relative to maximum drawdown

-0.90

1.51

-2.41

Martin ratioReturn relative to average drawdown

-1.21

3.82

-5.03

OM vs. MO - Sharpe Ratio Comparison

The current OM Sharpe Ratio is -0.80, which is lower than the MO Sharpe Ratio of 1.10. The chart below compares the historical Sharpe Ratios of OM and MO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


OMMODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.80

1.10

-1.90

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.64

0.77

-1.41

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.63

0.69

-1.33

Drawdowns

OM vs. MO - Drawdown Comparison

The maximum OM drawdown since its inception was -99.67%, which is greater than MO's maximum drawdown of -65.43%. Use the drawdown chart below to compare losses from any high point for OM and MO.


Loading charts...

Drawdown Indicators


OMMODifference

Max Drawdown

Largest peak-to-trough decline

-99.67%

-65.43%

-34.24%

Max Drawdown (1Y)

Largest decline over 1 year

-85.12%

-16.40%

-68.72%

Max Drawdown (3Y)

Largest decline over 3 years

-99.11%

-16.40%

-82.71%

Max Drawdown (5Y)

Largest decline over 5 years

-99.64%

-25.83%

-73.81%

Max Drawdown (10Y)

Largest decline over 10 years

-53.69%

Current Drawdown

Current decline from peak

-99.52%

-5.70%

-93.82%

Average Drawdown

Average peak-to-trough decline

-69.55%

-11.93%

-57.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

62.80%

6.48%

+56.32%

Volatility

OM vs. MO - Volatility Comparison

Outset Medical, Inc. (OM) has a higher volatility of 35.94% compared to Altria Group, Inc. (MO) at 7.41%. This indicates that OM's price experiences larger fluctuations and is considered to be riskier than MO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OMMODifference

Volatility (1M)

Calculated over the trailing 1-month period

35.94%

7.41%

+28.53%

Volatility (6M)

Calculated over the trailing 6-month period

63.89%

17.18%

+46.71%

Volatility (1Y)

Calculated over the trailing 1-year period

96.37%

22.42%

+73.95%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

99.68%

20.63%

+79.05%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

95.55%

22.94%

+72.61%

Dividends

OM vs. MO - Dividend Comparison

OM has not paid dividends to shareholders, while MO's dividend yield for the trailing twelve months is around 5.97%.


PositionTTM20252024202320222021202020192018201720162015
MO
Altria Group, Inc.
5.97%7.21%7.65%9.52%8.05%7.43%8.29%6.57%6.07%3.56%3.48%3.73%
OM
Outset Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

OM vs. MO - Financials Comparison

This section allows you to compare key financial metrics between Outset Medical, Inc. and Altria Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B20222023202420252026
27.86M
5.43B
(OM) Total Revenue
(MO) Total Revenue
Values in USD except per share items

OM vs. MO - Profitability Comparison

The chart below illustrates the profitability comparison between Outset Medical, Inc. and Altria Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
43.4%
64.6%
Portfolio components
OM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Outset Medical, Inc. reported a gross profit of 12.10M and revenue of 27.86M. Therefore, the gross margin over that period was 43.4%.

MO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported a gross profit of 3.51B and revenue of 5.43B. Therefore, the gross margin over that period was 64.6%.

OM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Outset Medical, Inc. reported an operating income of -16.92M and revenue of 27.86M, resulting in an operating margin of -60.7%.

MO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported an operating income of 2.96B and revenue of 5.43B, resulting in an operating margin of 54.5%.

OM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Outset Medical, Inc. reported a net income of -18.98M and revenue of 27.86M, resulting in a net margin of -68.1%.

MO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Altria Group, Inc. reported a net income of 2.18B and revenue of 5.43B, resulting in a net margin of 40.2%.


Frequently Asked Questions


OM and MO have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OM has higher volatility (35.94%) compared to MO (7.41%). In terms of maximum drawdown, OM dropped -99.67% vs MO's -65.43%.

MO currently has the higher Sharpe Ratio (1.10 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OM and MO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer